Corbus Pharmaceuticals Holding (CRBP) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.25
• Market Cap: $136.39M
• EPS: $-5.49
• 52-Week High: $20.56
• 52-Week Low: $4.64

Market Sentiment

Corbus Pharmaceuticals Holding currently has a Bullish sentiment score of 0.42.

About Corbus Pharmaceuticals Holding

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company located in Norwood, Massachusetts, specializing in the development of innovative therapies that target the endocannabinoid system to tackle pressing unmet medical needs in autoimmunity, fibrosis, and oncology. The company boasts a diverse and promising pipeline aimed at enhancing treatment modalities for chronic diseases, with the potential to reshape patient care paradigms. With its distinct approach to cannabino...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Corbus Pharmaceuticals Holding and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRBP pay dividends?

Corbus Pharmaceuticals Holding (CRBP) does not currently pay a regular dividend.

What is CRBP's market cap?

Corbus Pharmaceuticals Holding (CRBP) has a market capitalization of $136.39M with a current stock price of $8.25.